Newell, Laura F
Cook, Rachel J
Clinical trials referenced in this document:
Documents that mention this clinical trial
Advances in acute myeloid leukemia
https://doi.org/10.1136/bmj.n2026
Documents that mention this clinical trial
Use of platelet and erythroid growth factors during induction chemotherapy for acute lymphoblastic leukaemia in a Jehovah’s Witness
https://doi.org/10.1136/bcr-2018-226497
Advances in acute myeloid leukemia
https://doi.org/10.1136/bmj.n2026
Documents that mention this clinical trial
Advances in acute myeloid leukemia
https://doi.org/10.1136/bmj.n2026
Documents that mention this clinical trial
Advances in acute myeloid leukemia
https://doi.org/10.1136/bmj.n2026
Documents that mention this clinical trial
Advances in acute myeloid leukemia
https://doi.org/10.1136/bmj.n2026
Documents that mention this clinical trial
Advances in acute myeloid leukemia
https://doi.org/10.1136/bmj.n2026
Documents that mention this clinical trial
Advances in acute myeloid leukemia
https://doi.org/10.1136/bmj.n2026
Documents that mention this clinical trial
Advances in acute myeloid leukemia
https://doi.org/10.1136/bmj.n2026
Documents that mention this clinical trial
Advances in acute myeloid leukemia
https://doi.org/10.1136/bmj.n2026
Documents that mention this clinical trial
UCHMC 1812: A phase 1b trial of CPX-351 plus gemtuzumab ozogamicin for relapsed/refractory acute myeloid leukemia.
https://doi.org/10.1200/jco.2023.41.16_suppl.7024
Advances in acute myeloid leukemia
https://doi.org/10.1136/bmj.n2026
Documents that mention this clinical trial
Advances in acute myeloid leukemia
https://doi.org/10.1136/bmj.n2026
Documents that mention this clinical trial
Advances in acute myeloid leukemia
https://doi.org/10.1136/bmj.n2026